Disease/Infection News

RSS

Experimental two‑in‑one vaccine shows success in human LASSARAB trial

Researchers from Thomas Jefferson University and the University of Maryland School of Medicine have reported encouraging results from the first human clinical trial of LASSARAB, an experimental vaccine designed to protect against Lassa fever and rabies in a single formulation.

9 Jun 2026

Pharmacist prescribing could unlock $1 billion in savings; free 10 million GP visits and prevent 30,000 hospitalizations annually

New national modelling identifies pharmacist prescribing as a practical, scalable reform to improve access to care at a time when GP workforce shortages are projected to worsen.

9 Jun 2026

Study links menstrual cycle timing to COVID vaccine side effects

A study of 1,474 Clue app users found that women vaccinated against COVID-19 during the follicular phase had higher odds of self-reported side effects than those vaccinated during the luteal phase.

8 Jun 2026

Researchers find flaw in AI models for sepsis treatment

AI is already boosting positive outcomes in healthcare and holds promise for delivering many more. It is important, however, that deployment of AI tools - especially in a life-or-death healthcare setting - proceeds at a thoughtful and measured pace, cautions Shengpu Tang, assistant professor of computer science at Emory University.

8 Jun 2026

$3.8 million grant funds study on early lung immune responses to tuberculosis

A University of Minnesota Medical School research team was awarded a 5-year, $3.8 million grant from the National Institute of Allergy and Infectious Diseases to study early immune responses in the lung and how they influence tuberculosis infection outcomes.

8 Jun 2026

Study: Antibiotic resistance is increasing in Shiga toxin-producing E. coli

Resistance to antimicrobial agents is rising among human infections with Escherichia coli bacteria that produce the Shiga toxin, according to a study analyzing data from nearly 2,000 infections in the United States between 2010 and 2021.

8 Jun 2026

New project launches to advance chikungunya vaccine in Africa

Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.

8 Jun 2026

WHO's new estimates of foodborne diseases may improve global prevention

Researchers from DTU have contributed to the international scientific work behind the WHO's new estimates of the global burden of foodborne diseases, providing countries with a stronger evidence base for preventing illness and prioritising action.

8 Jun 2026

Defective HIV copies explain persistent viral traces during treatment

Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives.

8 Jun 2026

Research highlights ongoing TORCH infection risks despite rising vaccination rates

The TORCH complex is a group of pathogens that can cause infections with mild or silent symptoms in an expecting mother, but in a developing fetus can lead to serious complications that include stillbirth, lifelong disability, or birth defects.

8 Jun 2026

Africa CDC and WHO unite to combat Ebola outbreak

The Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) today launched a joint continental preparedness and response plan on the ongoing Ebola outbreak caused by the Bundibugyo virus.

7 Jun 2026

New open-access COVID-19 dataset supports reproducible clinical research

The Biostatistics Unit at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with researchers from several Catalan healthcare and research institutions, has published the DIVINE study database in Scientific Data, a Nature Portfolio journal.

5 Jun 2026

Novel technique enables rapid sequencing of rare hantaviruses

Infections by hantaviruses are rare but dangerous, killing 30-40% of infected people. When cases occur, public health officials need rapid, detailed information about the virus to identify the strain and its origin, so they can stop others from being exposed to the disease.

5 Jun 2026

Bee-derived propolis shows potent antiviral activity against varicella-zoster virus

Announcing a new article publication for Zoonoses journal. Varicella-zoster virus (VZV) is a clinically important human neurotropic herpesvirus that causes varicella (chickenpox) as primary infection, typically in children.

5 Jun 2026

Bio-Rad receives MicroVal validation for EZ-Check™ Listeria testing kits

Bio-Rad Laboratories, Inc., a leader in life science research and clinical diagnostics products, today announced that MicroVal, the international certification organization for the validation and approval of alternative methods for the microbiological analysis of food and beverages, has approved EZ-Check Listeria spp. and EZ-Check Listeria monocytogenes Kits for the detection of Listeria spp. and Listeria monocytogenes in food products and environmental samples.

From Bio-Rad Laboratories 5 Jun 2026

Flu drugs may reduce cognitive decline in people with HIV

A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and extended into preclinical drug trials.

5 Jun 2026

Home sewage overflows expose residents to dangerous drug-resistant bacteria

A new study shows that sewage overflows in homes can expose people to bacteria that can make them sick, including antibiotic-resistant and multidrug resistant bacteria which can make infections difficult to treat.

5 Jun 2026

UK manufacturer supplying Ebola response warns infection-control readiness cannot wait for crisis

As health agencies respond to the current Ebola outbreak in Central Africa, a UK manufacturer supplying water purification products for direct distribution in affected communities is warning that infection-control readiness must be planned long before an emergency takes hold.

5 Jun 2026

Untargeted metabolomics approach identifies potential biomarkers for latent tuberculosis diagnosis

Announcing a new article publication in BIO Integration. Latent tuberculosis infection (LTBI) is difficult to diagnose due to the lack of a definitive gold standard.

5 Jun 2026

Randox Health launches 'RanChip Insights 360'

Randox Health today announces the launch of RanChip Insight 360, an advanced health intelligence programme designed to transform how individuals understand, monitor, and manage their long-term wellbeing.

From Randox Laboratories Ltd. 5 Jun 2026